Table 1 Relationships between lncRNA AC010761.9 expression (ΔCt value) and patient clinical pathologic factors and serum tumor markers
From: Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma
Characteristics | No. of case (%) | Mean ± SD | p value |
|---|---|---|---|
Age | |||
≥ 60 | 70 (54.2) | 19.08 ± 2.904 | 0.162 |
< 60 | 59 (45.8) | 18.31 ± 3.309 | |
Gender | |||
Male | 102 (79.1) | 18.66 ± 3.087 | 0.620 |
Female | 27 (20.9) | 18.99 ± 3.227 | |
Tumor location | |||
Upper | 35 (28.0) | 19.33 ± 3.198 | 0.621 |
Middle | 48 (38.4) | 18.52 ± 3.062 | |
Lower | 42 (33.6) | 18.68 ± 3.140 | |
Diameter | |||
≥ 4 | 70 (54.2) | 19.28 ± 2.967 | 0.028 |
< 4 | 59 (45.8) | 18.07 ± 3.167 | |
Differentiation | |||
Poor | 97 (75.2) | 18.48 ± 3.096 | 0.047 |
Moderate | 30 (23.2) | 19.73 ± 2.966 | |
Well | 2 (1.6) | 15.39 ± 1.478 | |
Invasion | |||
T1 | 11 (8.5) | 18.08 ± 3.155 | 0.269 |
T2 | 11 (8.5) | 18.76 ± 4.302 | |
T3 | 14 (10.8) | 17.36 ± 3.074 | |
T4 | 93 (72.2) | 19.01 ± 2.931 | |
Lymphatic metastasis | |||
N0 | 32 (24.8) | 18.98 ± 3.274 | 0.597 |
N1–3 | 97 (75.2) | 18.64 ± 3.063 | |
Venous invasion | |||
Absent | 71 (55) | 18.67 ± 3.184 | 0.808 |
Present | 58 (45) | 18.80 ± 3.037 | |
Perineural invasion | |||
Absent | 59 (45.7) | 18.51 ± 3.243 | 0.399 |
Present | 70 (54.3) | 18.98 ± 2.946 | |
CEA | |||
Normal | 109 (84.5) | 18.48 ± 2.935 | 0.037 |
High | 20 (15.5) | 20.05 ± 3.727 | |
CA19-9 | |||
Normal | 113 (87.5) | 18.50 ± 2.999 | 0.026 |
High | 16 (12.5) | 20.34 ± 3.469 | |
AFP | |||
Normal | 121 (93.8) | 18.64 ± 3.082 | 0.248 |
High | 8 (6.2) | 19.96 ± 3.444 | |